The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy.
The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy.
复制标题
DOI:
10.1155/2017/1673081
复制
发表时间:
2017
影响因子:
4.3
通讯作者:
Miranda-Díaz AG
中科院分区:
文献类型:
--
作者:
Sifuentes-Franco S;Pacheco-Moisés FP;Rodríguez-Carrizalez AD;Miranda-Díaz AG
Diabetic polyneuropathy (DPN) is the most frequent and prevalent chronic complication of diabetes mellitus (DM). The state of persistent hyperglycemia leads to an increase in the production of cytosolic and mitochondrial reactive oxygen species (ROS) and favors deregulation of the antioxidant defenses that are capable of activating diverse metabolic pathways which trigger the presence of nitro-oxidative stress (NOS) and endoplasmic reticulum stress. Hyperglycemia provokes the appearance of micro- and macrovascular complications and favors oxidative damage to the macromolecules (lipids, carbohydrates, and proteins) with an increase in products that damage the DNA. Hyperglycemia produces mitochondrial dysfunction with deregulation between mitochondrial fission/fusion and regulatory factors. Mitochondrial fission appears early in diabetic neuropathy with the ability to facilitate mitochondrial fragmentation. Autophagy is a catabolic process induced by oxidative stress that involves the formation of vesicles by the lysosomes. Autophagy protects cells from diverse stress factors and routine deterioration. Clarification of the mechanisms involved in the appearance of complications in DM will facilitate the selection of specific therapeutic options based on the mechanisms involved in the metabolic pathways affected. Nowadays, the antioxidant agents consumed exogenously form an adjuvant therapeutic alternative in chronic degenerative metabolic diseases, such as DM.
登录
查看更多内容
影响因子:
16.2
作者:
Albers JW;Herman WH;Pop-Busui R;Feldman EL;Martin CL;Cleary PA;Waberski BH;Lachin JM;Diabetes Control and Complications Trial /Epidemiology of Diabetes Interventions and Complications Research Group
通讯作者:
Diabetes Control and Complications Trial /Epidemiology of Diabetes Interventions and Complications Research Group
影响因子:
7.7
作者:
Forbes, JM;Cooper, ME;Osicka, TM
通讯作者:
Osicka, TM
影响因子:
5.6
作者:
de M Bandeira S;da Fonseca LJ;da S Guedes G;Rabelo LA;Goulart MO;Vasconcelos SM
通讯作者:
Vasconcelos SM
影响因子:
4
作者:
Chen, Yongqiang;Klionsky, Daniel J.
通讯作者:
Klionsky, Daniel J.
DOI:
10.1152/ajpendo.00287.2009
发表时间:
2009-09-01
影响因子:
5.1
作者:
Askwith, Trevor;Zeng, Wei;Stevens, Martin J.
通讯作者:
Stevens, Martin J.